NYSDA Publications

NIH Issues Research Findings on COVID-19 and Heparan Sulfate

The National Institutes of Health (NIH) has issued research findings showing that the novel coronavirus (COVID-19) may use a key carbohydrate, heparan sulfate, to infect cells.  NIH notes that this may lead to new treatments where the drug heparin is repurposed to address COVID-19.  To read the NIH announcement and summary of its research findings on COVID-19 and heparan sulfate, use the link below.